Skip to main navigation Skip to search Skip to main content

TACE-2: A randomised placebo-controlled, double blinded, phase III trial of sorafenib in combination with Transarterial Chemoembolisation in hepatocellular cancer

Project Details

Short titleTACE-2: A randomised placebo-controlled, double blinded, phase III trial of sorafenib in combination with Transarterial Chemoembolisation in hepatocellular cancer
StatusFinished
Effective start/end date16/02/09 → 31/12/23

Funding

  • University College London